Physician profile
Abel Li
NPI 1841239399
$3,778.07
in general payments reported to CMS, 2019-2025
13 companies · $1,077 in 2025
The $1,077 reported for 2025 was more than what 79% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $515 · 2021: $563 · 2022: $680 · 2023: $733 · 2024: $104 · 2025: $1,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,913.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,827.74 | 2019-2025 | Clareon, Argos, Clareon Panoptix Pro |
| Abbvie INC. | $270.65 | 2023-2025 | |
| Sight Sciences, INC. | $182.01 | 2022-2023 | Omni Surgical System |
| Allergan, INC. | $181.43 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $97.40 | 2021 | |
| Astellas Pharma US INC | $41.84 | 2025 | Izervay |
| Regeneron Healthcare Solutions, INC. | $37.90 | 2025 | Eylea Hd |
| Aerie Pharmaceuticals, INC. | $33.06 | 2019 | |
| Glaukos Corporation | $26.50 | 2025 | Istent Infinite, Idosetr |
| Sun Pharmaceutical Industries INC. | $26.05 | 2025 | |
| Ani Pharmaceuticals, INC. | $20.11 | 2025 | Iluvien |
| Shire North American Group INC | $17.98 | 2019 | |
| Mallinckrodt Enterprises LLC | $15.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abel Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.